ETP-46464 is primarily utilized in the field of cancer research as a potent inhibitor targeting specific kinases involved in tumor growth and proliferation. It is often employed in preclinical studies to investigate its efficacy in suppressing signaling pathways that drive cancer progression, particularly in cases of drug-resistant malignancies. Researchers also explore its potential in combination therapies to enhance the effectiveness of existing treatments. Additionally, ETP-46464 serves as a valuable tool compound in biochemical assays to study kinase function and validate drug targets. Its application extends to the development of novel therapeutic strategies aimed at improving outcomes for patients with challenging cancers.